|1.||Kelly, Seth M: 2 articles (05/2014 - 07/2011)|
|2.||Leung, Sara W: 2 articles (05/2014 - 07/2011)|
|3.||Moberg, Kenneth H: 2 articles (05/2014 - 07/2011)|
|4.||Corbett, Anita H: 2 articles (05/2014 - 07/2011)|
|5.||Imperiale, L: 1 article (01/2015)|
|6.||Ruscito, I: 1 article (01/2015)|
|7.||Gasparri, M L: 1 article (01/2015)|
|8.||Palaia, I: 1 article (01/2015)|
|9.||Muzii, L: 1 article (01/2015)|
|10.||Casorelli, A: 1 article (01/2015)|
04/01/2006 - "Studies have examined genotypes for common VDR polymorphisms, including a single nucleotide polymorphism (SNP) detected by Bsm1, a polyadenosine [poly(A)] repeat polymorphism, and a SNP detected by Fok1, as candidates for susceptibility to cancer, but most have not evaluated haplotypes for these markers. "
09/15/2004 - "In contrast, frameshift mutations were found in neither of the polyadenosine tracts in 63 samples of MSI-L or MSI stable tumors. "
01/01/2015 - "Among such targets, polyadenosine diphosphate—ribose polymerase (PARP) represents a novel way to target specific patways involved in tumor growth. "
05/15/2010 - "On the other hand, treatment with CDB4124 increased levels of the apoptosis marker cleaved polyadenosine 5'-diphosphate-ribose polymerase and the tumor suppressor Krüppel-like transcription factor 11 in a dose- and time-dependent manner in LSM cells. "
10/01/2008 - "Polyadenosine diphosphate-ribose polymerase (PARP) inhibitors are emerging as an exciting new class of agents for treating cancer. "
|3.||Stomach Neoplasms (Stomach Cancer)
03/01/2001 - "Enhanced polyadenosine diphosphate-ribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinoma."
10/15/1998 - "Alteration in a polycytidine (C)n tract within a non-coding displacement-loop (D-loop) region was detected in 20 carcinomas (44%), three of which also exhibited frameshift mutations in a polyadenosine (A)8 or polycytidine (C)6 tract within NADH dehydrogenase (ND) genes. "
09/01/2000 - "Frameshift mutations in the two coding polyadenosine tracks of RIZ were found in 19 (48%) of 40 gastric carcinomas, 6 (33%) of 18 endometrial carcinomas, 14 (26%) of 51 of colorectal carcinomas, and 7 (54%) of 13 cell lines. "
04/01/2005 - "Polyadenosine diphosphate-ribose polymerase (PARP) has been implicated as a mediator of inflammation and tissue necrosis in murine models of human stroke and myocardial infarction. "
06/01/2000 - "The expression of neuron-type glutamate transporters (EAAC-1), AMPA glutamate receptor subunits (GluR1 and GluR2/3), polyadenosine (5'diphosphate-ribose) polymerase (PARP), and transforming growth factor-beta1 was investigated in 20 cases of neonatal pontosubicular neuron necrosis and 12 gestational-age matched controls. "
|4.||Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
|5.||RNA-Binding Proteins (RNA-Binding Protein)
|7.||A-Form DNA (A-DNA)
|8.||Glutamic Acid (Glutamate)
|9.||alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
|10.||Glutamate Receptors (Glutamate Receptor)